DBOL

Dhampur Bio Organics Financial Results

₹140.37+1.79%
Market cap
₹923 crore
P/E
27.6
P/B
0.90
ROE
2.5%
Dividend yield
1.07%

For the year ended Mar 2023, Dhampur Bio Organics reported revenue of ₹2,367 crore and net profit of ₹111 crore, against ₹1,839 crore and ₹46 crore a year earlier.

Dhampur Bio Organics annual profit and loss

Financial years, newest first. TTM = trailing twelve months.

Dhampur Bio Organics annual profit and loss (₹ crore)
ItemMar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue2,3671,8391,8432,0742,117
Expenses2,1541,6971,7071,9331,978
Operating profit212142136141138
Operating margin %9%8%7%7%7%
Other income116-21931
Interest3843656057
Depreciation4149545957
Profit before tax13565164156
Tax %18%29%6%38%40%
Net profit11146152533
EPS (₹)16.747.002.213.835.08
Dividend payout %—————

Source: Company filings (consolidated), in ₹ crore. Data as of 7 October 2026. How this data is compiled.

Dhampur Bio Organics financial results — frequently asked questions

What is Dhampur Bio Organics' annual revenue and net profit?

For the financial year ended Mar 2023, Dhampur Bio Organics' revenue was ₹2,367 crore and net profit ₹111 crore; net profit rose 141.30% from ₹46 crore in Mar 2024.

How fast has Dhampur Bio Organics grown over three years?

From Mar 2026 to Mar 2023, Dhampur Bio Organics' revenue grew at a compound annual rate of 4.5% and net profit at 64.4%. Past growth does not indicate future results.

What is the EPS of Dhampur Bio Organics?

Annual EPS for Mar 2023 was ₹16.74.

Are these figures consolidated or standalone?

They are consolidated figures as reported by the company, in ₹ crore. Trailing-twelve-month and half-year columns are labelled separately and are not counted as financial years.

Same Data For Peers

Trade Dhampur Bio Organics With ATS

Track DBOL live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.